Loading…
Lobbying Spend
—
Filings
4
Firms Hired
1
Active Period
2011
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Issues related to Dextromethorphan; issues related to Pseudoephedrine; issues related to the regulation of Cosmetic Productions; isses relating to the McNeil recall of over the counter medications; HR 2359, "Safe Cosmetics Act of 2011," regarding all provisions.
Client expense: — · Firm income: $51,000
Matched citations: HR 2359
Issues related to Dextromethorphan; issues related to Pseudoephedrine; issues related to the regulation of Cosmetic Productions; isses relating to the McNeil recall of over the counter medications; HR 2359, "Safe Cosmetics Act of 2011," regarding all provisions.
Client expense: — · Firm income: $51,000
Matched citations: HR 2359
Issues related to the Medical Device User Fee Program and to FDA regulated medical devices and the Regulation & Reimbursement of Diagnostics, regarding all provisions; issues related to dextromethorphan, pseudoephedrine, regulation of cosmetic productions, and HR 2359, "Safe Cosmetics Act of 2011"
Client expense: — · Firm income: —
Matched citations: HR 2359
Issues related to the Medical Device User Fee Program and to FDA regulated medical devices and the Regulation & Reimbursement of Diagnostics, regarding all provisions; issues related to dextromethorphan, pseudoephedrine, regulation of cosmetic productions, and HR 2359, "Safe Cosmetics Act of 2011"
Client expense: — · Firm income: —
Matched citations: HR 2359
Source: Senate LDA